10 December 2025
Cancers | Highly Viewed Special Issues on Cancer Immunology and Immunotherapy
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to share some highly viewed Special Issues on cancer immunology and immunotherapy in Cancers (ISSN: 2072-6694). Some of them are still open for submission. The following is a list of the Special Issues that we believe will interest you.
Special Issues:
“T Cells in Hematologic Malignancies: Biology, Microenvironment, and Therapeutic Advances”
Guest Editor: Dr. Maria Velegraki
Submission deadline: 16 September 2026

“Neoantigen Vaccines for Cancer Therapy”
Guest Editor: Dr. Takashi Morisaki
Submission deadline: 30 August 2026

“Immunotherapy for Acute Lymphoblastic Leukemia: Novel Strategies and Clinical Perspectives”
Guest Editors: Dr. Paola Minetto and Dr. Francesco Grimaldi
Submission deadline: 30 June 2026

“The Tumor Microenvironment and Molecular Aberrations Convey Immune Evasion (Third Edition)”
Guest Editor: Dr. Huey-Jen Lin
Submission deadline: 30 September 2026

“Opportunities and Challenges in Cancer Immunotherapies”
Guest Editor: Dr. Gao Zhang
Submission deadline: 31 October 2026

“Antibodies and Their Derivatives in Cancer Immunotherapy for Gastrointestinal Cancers”
Guest Editors: Dr. Kiran Kundu and Dr. Susmita Ghosh
Submission deadline: 24 July 2026

You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers.
Cancers Editorial Office